Literature DB >> 29892934

Minimally invasive esophagectomy in the prone position improves postoperative outcomes: role of C-reactive protein as an indicator of surgical invasiveness.

Kazuo Koyanagi1, Soji Ozawa2, Yuji Tachimori3.   

Abstract

BACKGROUND: The aim of the study was to assess serum C-reactive protein (CRP) level immediately after minimally invasive esophagectomy (MIE) as a surrogate of surgical invasiveness in patients who underwent esophagectomy.
METHODS: In total, 104 patients were enrolled in the study: 37 patients underwent MIE in the left lateral decubitus position (MIE-LP) and 67 patients underwent MIE in the prone position (MIE-PP). Serum CRP levels were assessed on POD 1, 3, 5, and 7 after MIE, and were compared with surgical outcomes and duration of systemic inflammatory response syndrome (SIRS) to investigate less invasiveness of the MIE.
RESULTS: Reduced serum CRP level on POD 1 was associated with PP during MIE (P < 0.001) and decreased blood loss (P = 0.03). MIE-PP was identified as a significant independent predictor of reduced CRP level on POD 1 (odds ratio 3.65, P = 0.042). CRP level on POD 7 was associated with gender (P = 0.02), position of MIE (P = 0.011), blood loss (P = 0.02), and respiratory complications and/or anastomotic leakage (P < 0.001). Postoperative respiratory and/or anastomotic complication was identified as a significant predictor of elevated serum CRP level on POD 7 (odds ratio 3.44, P = 0.048). Shorter duration of SIRS was shown in the patients with reduced serum CRP level on POD 1 and 7 (P = 0.03 and P < 0.001, respectively).
CONCLUSION: Serial assessments of serum CRP level immediately after MIE may be a possible indicator that can reflect surgical invasiveness and postoperative complications.

Entities:  

Keywords:  C-reactive protein; Esophageal cancer; Minimally invasive esophagectomy

Mesh:

Substances:

Year:  2018        PMID: 29892934     DOI: 10.1007/s10388-017-0602-8

Source DB:  PubMed          Journal:  Esophagus        ISSN: 1612-9059            Impact factor:   4.230


  14 in total

1.  Endoscopic oesophagectomy through a right thoracoscopic approach.

Authors:  A Cuschieri; S Shimi; S Banting
Journal:  J R Coll Surg Edinb       Date:  1992-02

2.  Better postoperative oxygenation in thoracoscopic esophagectomy in prone positioning.

Authors:  Tomoaki Yatabe; Hiroyuki Kitagawa; Koichi Yamashita; Toyokazu Akimori; Kazuhiro Hanazaki; Masataka Yokoyama
Journal:  J Anesth       Date:  2010-06-05       Impact factor: 2.078

Review 3.  Minimally invasive esophagectomy performed with the patient in a prone position: a systematic review.

Authors:  Kazuo Koyanagi; Soji Ozawa; Yuji Tachimori
Journal:  Surg Today       Date:  2015-04-10       Impact factor: 2.549

4.  Role of Postoperative C-Reactive Protein Levels in Predicting Prognosis After Surgical Treatment of Esophageal Cancer.

Authors:  Yuta Ibuki; Yoichi Hamai; Jun Hihara; Manabu Emi; Junya Taomoto; Takaoki Furukawa; Ichiko Yamakita; Tomoaki Kurokawa; Morihito Okada
Journal:  World J Surg       Date:  2017-06       Impact factor: 3.352

5.  Recurrent Laryngeal Nerve Paralysis after Esophagectomy: Respiratory Complications and Role of Nerve Reconstruction.

Authors:  Kazuo Koyanagi; Hiroyasu Igaki; Jun Iwabu; Hiroki Ochiai; Yuji Tachimori
Journal:  Tohoku J Exp Med       Date:  2015-09       Impact factor: 1.848

6.  Minimally invasive esophagectomy: outcomes in 222 patients.

Authors:  James D Luketich; Miguel Alvelo-Rivera; Percival O Buenaventura; Neil A Christie; James S McCaughan; Virginia R Litle; Philip R Schauer; John M Close; Hiran C Fernando
Journal:  Ann Surg       Date:  2003-10       Impact factor: 12.969

7.  A comparison of video-assisted thoracoscopic oesophagectomy and radical lymph node dissection for squamous cell cancer of the oesophagus with open operation.

Authors:  H Osugi; M Takemura; M Higashino; N Takada; S Lee; H Kinoshita
Journal:  Br J Surg       Date:  2003-01       Impact factor: 6.939

8.  Rising C-reactive protein and procalcitonin levels precede early complications after esophagectomy.

Authors:  Sandra H Hoeboer; A B Johan Groeneveld; Noel Engels; Michel van Genderen; Bas P L Wijnhoven; Jasper van Bommel
Journal:  J Gastrointest Surg       Date:  2015-02-07       Impact factor: 3.452

9.  Fast-track surgery improves postoperative clinical recovery and cellular and humoral immunity after esophagectomy for esophageal cancer.

Authors:  Lantao Chen; Lixin Sun; Yaoguo Lang; Jun Wu; Lei Yao; Jinfeng Ning; Jinfeng Zhang; Shidong Xu
Journal:  BMC Cancer       Date:  2016-07-11       Impact factor: 4.430

10.  Comprehensive Registry of Esophageal Cancer in Japan, 2009.

Authors:  Yuji Tachimori; Soji Ozawa; Hodaka Numasaki; Mitsuhiro Fujishiro; Hisahiro Matsubara; Tsuneo Oyama; Masayuki Shinoda; Yasushi Toh; Harushi Udagawa; Takashi Uno
Journal:  Esophagus       Date:  2016-03-29       Impact factor: 4.230

View more
  4 in total

1.  Prevention of intra-thoracic recurrent laryngeal nerve injury with robot-assisted esophagectomy.

Authors:  Kei Hosoda; Masahiro Niihara; Hideki Ushiku; Hiroki Harada; Mikiko Sakuraya; Marie Washio; Keishi Yamashita; Naoki Hiki
Journal:  Langenbecks Arch Surg       Date:  2020-06-03       Impact factor: 3.445

2.  Lateral thermal spread and recurrent laryngeal nerve paralysis after minimally invasive esophagectomy in bipolar vessel sealing and ultrasonic energy devices: a comparative study.

Authors:  Kazuo Koyanagi; Fumihiko Kato; Keita Nakanishi; Soji Ozawa
Journal:  Esophagus       Date:  2018-05-31       Impact factor: 4.230

3.  Adverse outcomes of artificial pneumothorax under right bronchial occlusion for patients with thoracoscopic-assisted oesophagectomy in the prone position versus the semiprone position.

Authors:  Qiongzhen Li; Mingye Zhao; Dongjin Wu; Xufeng Guo; Jingxiang Wu
Journal:  Front Oncol       Date:  2022-08-09       Impact factor: 5.738

Review 4.  p53 molecular approach to diagnosis and treatment of esophageal squamous cell carcinoma.

Authors:  Hideaki Shimada
Journal:  Ann Gastroenterol Surg       Date:  2018-06-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.